Sensorimotor Tests – Pre-Pulse Inhibition (PPI)
Pre-Pulse Inhibition (PPI) allows you to study sensorimotor gating in various neuropsychiatric and neurological disorder mouse models
Key Research Model Applications of Pre-Pulse Inhibition
Prepulse inhibition (PPI) is a phenomenon whereby a startle reflex in response to an intense acoustic stimulus is suppressed when a weak pulse precedes the startle stimulus by 30-500 milliseconds. PPI is an automatic early-stage gating process contributing to the ability to focus attention, which is disrupted in several neuropsychiatric disorders like schizophrenia. Sensorimotor gating reflects brain’s ability to filter out irrelevant stimuli (i.e., in this case, weak pulse) and prevent them from overwhelming the processing of more important stimuli (i.e., in this case, intense acoustic stimulus)
Sensorimotor gating deficits are detectable in mice lacking Pcdh9 (Bruining et al 2015), different recombinant inbred strains (Loos et al. 2012) and in the 22q11 mouse model relevant to study Schizophrenia.

Mouse Behavioral Testing Made Simple.
Explore our extensive portfolio of validated and tailored behavioral and cognitive rodent tests designed to advance your research.
Pre-Pulse Inhibition Sample Data

The auditory pre-pulse inhibition (PPI) test is a highly translational test for sensorimotor gating in humans and rodents.

The auditory pre-pulse inhibition (PPI) test is a highly translational test for sensorimotor gating in humans and rodents.
Heterozygous deletion of genes residing in the human 22q11 chromosomal region leads to a robust deficit in sensorimotor gating in comparison with control litter mates. In line with previous publications, we detected deficits in working memory in the 8-arm radial maze in 22q11 mutants.
The People Behind Your Research
Thomas Vogels, PhD, In Vivo Neurology Study Director
Leads an expert team of scientists with vast experience in our Neurology models to help you choose the right model and guide your optimal study design. We provide the solution to accelerating your drug development.
Stay Curious: More Articles to Explore
info@innoserlaboratories.com
AAALAC Accreditation
InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.
Animal Welfare
The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.